The effect of age on the pharmacokinetics and pharmacodynamics of midazolam

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 6, 1999, Pages 630-639

  Albrecht, Sven ^a,b   Ihmsen, Harald ^a,b   Hering, Werner ^a,b   Geisslinger, Gerd ^a,b   Dingemanse, Jasper ^a,b   Schwilden, Helmut ^a,b   Schüttler, Jürgen ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b E Hoffmann La Roche ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM;

ADULT; AGE; AGED; ARTICLE; AUDITORY STIMULATION; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYSTERESIS; MALE; PRIORITY JOURNAL; SEDATION; STEADY STATE;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MALE; MIDAZOLAM; RESPIRATION; VOLUNTARY WORKERS;

EID: 0033017570     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)90084-X     Document Type: Article

References (32)

1. 1. Gerecke M. Chemical structure and properties of midazolam compared with other benzodiazepines. Br J Clin Pharmacol 1983;16:11S-6S.
2. 2. Greenblatt DJ, Shader RI, Divoll M, Harmatz JS. Benzodiazepines: a summary of pharmacokinetic properties. Br J Clin Pharmacol 1981;11:11S-6S.
3. 3. Brown CR, Sarnquist FH, Canup CA, Pedley TA. Clinical, electroencephalographic, and pharmacokinetic studies of a water-soluble benzodiazepine, midazolam maleate. Anesthesiology 1979;50:467-70.
4. 4. Dundee JW, Samuel IO, Toner W, Howard PJ. Midazolam: a water-soluble benzodiazepine. Anaesthesia 1980; 35:454-8.
5. 5. Gamble JAS, Kawar P, Dundee JW, Moore J, Briggs LP. Evaluation of midazolam as an intravenous induction agent. Anaesthesia 1981;36:868-73.
6. 6. Pakkanen A, Kanto J. Midazolam compared with thiopentone as an induction agent. Acta Anaesthesiol Scand 1982;26:143-6.
7. 7. Breimer LTM, Burm AGL, Danhof M, Hennis PJ, Vletter AA, de Voogt JWH, et al. Pharmacokinetic-pharmacodynamic modeling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis. Clin Pharmacokinet 1991;20:497-508.
8. 8. Bührer M, Maitre PO, Crevoisier C, Stanski DR. Electroencephalographic effects of benzodiazepines; II: pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther 1990;48:555-67.
9. 9. Greenblatt DJ, Ehrenberg BL, Gundermann J, Locniskar A, Scavone JM, Harmatz JS, et al. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 1989;45:356-65.
10. 10. Laurijssens BE, Greenblatt DJ. Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clin Pharmacokinet 1996;30:52-76.
11. 11. Schwilden H, Stoeckel H. The derivation of EEG parameters for modelling and control of anaesthetic drug effect. In: Stoeckel H, editor. Quantitation, modelling and control in anaesthesia. Stuttgart: Thieme; 1985. p. 160-8.
12. 12. Hering WJ, Ihmsen H, Langer H, Uhrlau C, Dinkel M, Geisslinger G, et al. Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers. Anesthesiology 1996;85:1290-9.
13. 13. Schnider TW, Minto CF, Stanski DR. The effect compartment concept in pharmacodynamic modeling. Anaesth Pharmacol Rev 1994;2:204-13.
14. 14. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990;10:244-51.
15. 15. Schwilden H. A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol 1981;20:379-86.
16. 16. Fragen RJ, Gahl F, Caldwell N. A water-soluble benzodiazepine, Ro 21-3981, for induction of anesthesia. Anesthesiology 1978;49:41-3.
17. 17. Forster A, Gardaz JP, Suter PM, Gemperle M. IV midazolam as an induction agent for anaesthesia: a study in volunteers. Br J Anaesth 1980;52:907-11.
18. 18. Theil DR, Stanley TE, White WD, Goodman DK, Glass PS, Bai SA, et al. Midazolam and fentanyl continuous infusion anesthesia for cardiac surgery: a comparison of computer-assisted versus manual infusion systems. J Cardiothorac Vasc Anesth 1993;7:300-6.
19. 19. Klotz U. Clinical pharmacology of midazolam. Anaesthesiol Reanim 1989;14:347-54.
20. 20. Platten HP, Schweizer E, Dilger K, Mikus G, Klotz U. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther 1998;63:552-60.
21. 21. Avram MJ, Fragen RJ, Caldwell NJ. Midazolam kinetics in women of two age groups. Clin Pharmacol Ther 1983; 34:505-8.
22. 22. Lauven PM, Stoeckel H, Ochs H, Greenblatt DJ. Pharmacokinetics of midazolam in man. Anaesthesist 1981; 30:280-3.
23. 23. Hudson RJ. Midazolam pharmacokinetics in patients undergoing abdominal aortic surgery. Anesth Analg 1994;79:219-25.
24. 24. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;61:27-35.
25. 25. Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther 1997; 61:331-9.
26. 26. Hudson RJ, Stanski DR, Saidman LJ, Meathe E. A model for studying depth of anesthesia and acute tolerance of thiopental. Anesthesiology 1983;59:301-8.
27. 27. Schwilden H, Schüttler J, Stoeckel H. Quantitation of the EEG and pharmacodynamic modeling of hypnotic drugs: etomidate as an example. Eur J Anesthesiol 1985;2:121-31.
28. 28. Schüttler J, Stoeckel H, Schwilden H. Pharmacokinetic and pharmacodynamic modeling of propofol ('Diprivan') in volunteers and surgical patients. Postgrad Med J 1985;61(suppl 3):53-4.
29. 29. Dingemanse J. Kinetics and dynamics of drug effects on the nervous system. In: van Boxtel CJ, Holford NHG, Danhof M, editors. The in vivo study of drug action: principles and applications of kinetic-dynamic modeling. Amsterdam: Elsevier; 1992. p. 113-32.
30. 30. Hughes MA, Glass PS, Jacobs JR. Context-sensitive halftime in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-41.
31. 31. Barnett A, Fiore JW. Acute tolerance to diazepam in cats and its possible relationship to diazepam metabolism. Eur J Pharmacol 1971;13:239-43.
32. 32. Kroboth PD, Smith RB, Erb RJ. Tolerance to alprazolam after intravenous bolus and continuous infusion: psychomotor and EEG effects. Clin Pharmacol Ther 1988; 43:270-7.